These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

678 related items for PubMed ID: 32407961

  • 1. Cantharidin treatment inhibits hepatocellular carcinoma development by regulating the JAK2/STAT3 and PI3K/Akt pathways in an EphB4-dependent manner.
    Zhu M, Shi X, Gong Z, Su Q, Yu R, Wang B, Yang T, Dai B, Zhan Y, Zhang D, Zhang Y.
    Pharmacol Res; 2020 Aug; 158():104868. PubMed ID: 32407961
    [Abstract] [Full Text] [Related]

  • 2. Alpinia oxyphylla oil induces apoptosis of hepatocellular carcinoma cells via PI3K/Akt pathway in vitro and in vivo.
    Hui F, Qin X, Zhang Q, Li R, Liu M, Ren T, Zhao M, Zhao Q.
    Biomed Pharmacother; 2019 Jan; 109():2365-2374. PubMed ID: 30551496
    [Abstract] [Full Text] [Related]

  • 3. Sorafenib inhibits growth and metastasis of hepatocellular carcinoma by blocking STAT3.
    Gu FM, Li QL, Gao Q, Jiang JH, Huang XY, Pan JF, Fan J, Zhou J.
    World J Gastroenterol; 2011 Sep 14; 17(34):3922-32. PubMed ID: 22025881
    [Abstract] [Full Text] [Related]

  • 4. Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3.
    Subramaniam A, Shanmugam MK, Ong TH, Li F, Perumal E, Chen L, Vali S, Abbasi T, Kapoor S, Ahn KS, Kumar AP, Hui KM, Sethi G.
    Br J Pharmacol; 2013 Oct 14; 170(4):807-21. PubMed ID: 23848338
    [Abstract] [Full Text] [Related]

  • 5. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
    Xie L, Li M, Liu D, Wang X, Wang P, Dai H, Yang W, Liu W, Hu X, Zhao M.
    Molecules; 2019 Jan 22; 24(3):. PubMed ID: 30678274
    [Abstract] [Full Text] [Related]

  • 6. Local anesthetic bupivacaine inhibits proliferation and metastasis of hepatocellular carcinoma cells via suppressing PI3K/Akt and MAPK signaling.
    Wang L, Guo W, Guan H, Yan N, Cai X, Zhu L.
    J Biochem Mol Toxicol; 2021 Oct 22; 35(10):e22871. PubMed ID: 34338398
    [Abstract] [Full Text] [Related]

  • 7. SB365 inhibits angiogenesis and induces apoptosis of hepatocellular carcinoma through modulation of PI3K/Akt/mTOR signaling pathway.
    Hong SW, Jung KH, Lee HS, Choi MJ, Son MK, Zheng HM, Hong SS.
    Cancer Sci; 2012 Nov 22; 103(11):1929-37. PubMed ID: 22909393
    [Abstract] [Full Text] [Related]

  • 8. Eukaryotic elongation factor 2 kinase promotes angiogenesis in hepatocellular carcinoma via PI3K/Akt and STAT3.
    Zhou Y, Li Y, Xu S, Lu J, Zhu Z, Chen S, Tan Y, He P, Xu J, Proud CG, Xie J, Shen K.
    Int J Cancer; 2020 Mar 01; 146(5):1383-1395. PubMed ID: 31286509
    [Abstract] [Full Text] [Related]

  • 9. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.
    Zhang DM, Liu JS, Deng LJ, Chen MF, Yiu A, Cao HH, Tian HY, Fung KP, Kurihara H, Pan JX, Ye WC.
    Carcinogenesis; 2013 Jun 01; 34(6):1331-42. PubMed ID: 23393227
    [Abstract] [Full Text] [Related]

  • 10. Anticancer activity of dietary xanthone α-mangostin against hepatocellular carcinoma by inhibition of STAT3 signaling via stabilization of SHP1.
    Zhang H, Tan YP, Zhao L, Wang L, Fu NJ, Zheng SP, Shen XF.
    Cell Death Dis; 2020 Jan 24; 11(1):63. PubMed ID: 31980595
    [Abstract] [Full Text] [Related]

  • 11. Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma cells.
    Yang J, Cai X, Lu W, Hu C, Xu X, Yu Q, Cao P.
    Cancer Lett; 2013 Jan 28; 328(2):243-51. PubMed ID: 23032719
    [Abstract] [Full Text] [Related]

  • 12. Homoharringtonine suppresses tumor proliferation and migration by regulating EphB4-mediated β-catenin loss in hepatocellular carcinoma.
    Zhu M, Gong Z, Wu Q, Su Q, Yang T, Yu R, Xu R, Zhang Y.
    Cell Death Dis; 2020 Aug 14; 11(8):632. PubMed ID: 32801343
    [Abstract] [Full Text] [Related]

  • 13. Da-Chai-Hu-Tang Formula inhibits the progression and metastasis in HepG2 cells through modulation of the PI3K/AKT/STAT3-induced cell cycle arrest and apoptosis.
    Duan ZW, Liu Y, Zhang PP, Hu JY, Mo ZX, Liu WQ, Ma X, Zhou XH, Wang XH, Hu XH, Wei SL.
    J Ethnopharmacol; 2024 Sep 15; 331():118293. PubMed ID: 38705430
    [Abstract] [Full Text] [Related]

  • 14. IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma.
    Gu FM, Li QL, Gao Q, Jiang JH, Zhu K, Huang XY, Pan JF, Yan J, Hu JH, Wang Z, Dai Z, Fan J, Zhou J.
    Mol Cancer; 2011 Dec 15; 10():150. PubMed ID: 22171994
    [Abstract] [Full Text] [Related]

  • 15. LINC01133 aggravates the progression of hepatocellular carcinoma by activating the PI3K/AKT pathway.
    Zheng YF, Zhang XY, Bu YZ.
    J Cell Biochem; 2019 Mar 15; 120(3):4172-4179. PubMed ID: 30548306
    [Abstract] [Full Text] [Related]

  • 16. Ropivacaine suppresses tumor biological characteristics of human hepatocellular carcinoma via inhibiting IGF-1R/PI3K/AKT/mTOR signaling axis.
    Zhang R, Lian Y, Xie K, Cai Y, Pan Y, Zhu Y.
    Bioengineered; 2021 Dec 15; 12(2):9162-9173. PubMed ID: 34696683
    [Abstract] [Full Text] [Related]

  • 17. Ophiopogonin‑B targets PTP1B to inhibit the malignant progression of hepatocellular carcinoma by regulating the PI3K/AKT and AMPK signaling pathways.
    Yuan F, Gao Q, Tang H, Shi J, Zhou Y.
    Mol Med Rep; 2022 Apr 15; 25(4):. PubMed ID: 35169857
    [Abstract] [Full Text] [Related]

  • 18. Single Agent and Synergistic Activity of the "First-in-Class" Dual PI3K/BRD4 Inhibitor SF1126 with Sorafenib in Hepatocellular Carcinoma.
    Singh AR, Joshi S, Burgoyne AM, Sicklick JK, Ikeda S, Kono Y, Garlich JR, Morales GA, Durden DL.
    Mol Cancer Ther; 2016 Nov 15; 15(11):2553-2562. PubMed ID: 27496136
    [Abstract] [Full Text] [Related]

  • 19. Development of a novel azaspirane that targets the Janus kinase-signal transducer and activator of transcription (STAT) pathway in hepatocellular carcinoma in vitro and in vivo.
    Mohan CD, Bharathkumar H, Bulusu KC, Pandey V, Rangappa S, Fuchs JE, Shanmugam MK, Dai X, Li F, Deivasigamani A, Hui KM, Kumar AP, Lobie PE, Bender A, Basappa, Sethi G, Rangappa KS.
    J Biol Chem; 2014 Dec 05; 289(49):34296-307. PubMed ID: 25320076
    [Abstract] [Full Text] [Related]

  • 20. ZnAs@SiO2 nanoparticles as a potential anti-tumor drug for targeting stemness and epithelial-mesenchymal transition in hepatocellular carcinoma via SHP-1/JAK2/STAT3 signaling.
    Huang Y, Zhou B, Luo H, Mao J, Huang Y, Zhang K, Mei C, Yan Y, Jin H, Gao J, Su Z, Pang P, Li D, Shan H.
    Theranostics; 2019 Dec 05; 9(15):4391-4408. PubMed ID: 31285768
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.